These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structural implication for the impaired binding of W150A mutant LOX-1 to oxidized low density lipoprotein, OxLDL. Nakano S; Sugihara M; Yamada R; Katayanagi K; Tate S Biochim Biophys Acta; 2012 May; 1824(5):739-49. PubMed ID: 22369967 [TBL] [Abstract][Full Text] [Related]
5. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721 [TBL] [Abstract][Full Text] [Related]
6. Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis. Tomar A; Sahoo S; Aathi M; Kuila S; Khan MA; Ravi GRR; Jeyaraman J; Mehta JL; Varughese KI; Arockiasamy A Biochem Biophys Res Commun; 2022 Oct; 623():59-65. PubMed ID: 35872543 [TBL] [Abstract][Full Text] [Related]
7. Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1). Ohki I; Amida H; Yamada R; Sugihara M; Ishigaki T; Tate S Biochim Biophys Acta; 2011 Feb; 1814(2):345-54. PubMed ID: 21035571 [TBL] [Abstract][Full Text] [Related]
8. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects. Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767 [TBL] [Abstract][Full Text] [Related]
9. Protamine may have anti-atherogenic potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1. Takemura Y; Okamoto M; Hasegawa M; Hatanaka K; Kubota S Biosci Biotechnol Biochem; 2019 Jun; 83(6):1094-1101. PubMed ID: 30871430 [TBL] [Abstract][Full Text] [Related]
10. [Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages]. Bao HL; Liao FJ; Fang L; Zhong F; Liu W; Li JQ Zhonghua Xin Xue Guan Bing Za Zhi; 2019 May; 47(5):367-373. PubMed ID: 31142080 [No Abstract] [Full Text] [Related]
11. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage. Kakinuma T; Yasuda T; Nakagawa T; Hiramitsu T; Akiyoshi M; Akagi M; Sawamura T; Nakamura T Arthritis Rheum; 2004 Nov; 50(11):3495-503. PubMed ID: 15529384 [TBL] [Abstract][Full Text] [Related]
12. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. Biocca S; Filesi I; Mango R; Maggiore L; Baldini F; Vecchione L; Viola A; Citro G; Federici G; Romeo F; Novelli G J Mol Cell Cardiol; 2008 Mar; 44(3):561-70. PubMed ID: 18191942 [TBL] [Abstract][Full Text] [Related]
13. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Li DY; Chen HJ; Mehta JL Cardiovasc Res; 2001 Oct; 52(1):130-5. PubMed ID: 11557241 [TBL] [Abstract][Full Text] [Related]
14. The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding. Francone OL; Tu M; Royer LJ; Zhu J; Stevens K; Oleynek JJ; Lin Z; Shelley L; Sand T; Luo Y; Kane CD J Lipid Res; 2009 Mar; 50(3):546-555. PubMed ID: 18845619 [TBL] [Abstract][Full Text] [Related]
15. Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophy induced by oxidized low-density lipoprotein. Zhao Y; Li Y; Ning X; Chen K; Zhang S Biochem Biophys Res Commun; 2017 Aug; 490(1):55-61. PubMed ID: 28595908 [TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1. Kang BY; Mehta JL J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of LOX-1 by statins may relate to upregulation of eNOS. Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125 [TBL] [Abstract][Full Text] [Related]
18. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059 [TBL] [Abstract][Full Text] [Related]
19. Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin. Prochnau D; Rödel J; Prager K; Kuersten D; Heller R; Straube E; Figulla HR Acta Microbiol Immunol Hung; 2010 Jun; 57(2):147-55. PubMed ID: 20587387 [TBL] [Abstract][Full Text] [Related]
20. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]